Clalit HMO, Octopus.Health and IQVIA Introduce AI-Based Platform to Improve Patient Adherence to Treatment
NEW YORK, October 4, 2021 / PRNewswire / – Quality health care outcomes depend in large part on patients’ adherence to recommended treatment regimens. All the more so when it comes to treating patients with chronic and complex illnesses. Clalit data, that of Israel larger HMO, shows that approximately 50% of its chronic patients do not adhere to recommended medical treatment, which adversely affects outcomes of care.
A collaboration between Clalit HMO, IQVIA and Octopus.Health, a start-up co-founded by Clalit and IQVIA, resulted in the design, development and implementation of an AI-based platform that identifies patients who need better support to comply and adhere to their medical treatment plans. The platform was integrated with Clalit systems earlier this year, targeting 300,000 chronic Clalit patients, studying their preferences and interacting with them to improve adherence to their treatment plans. The large-scale implementation of the platform has already provided measurable clinical impact and indicates significant results.
The system’s interaction with patients is personalized based on their demographic and clinical data, and applies trial and error models of behavioral economics to increase its effectiveness. Once treatment gaps are identified, the system begins to interact with the patient to understand these gaps and address them by introducing accessible health services. For example, in the event that an essential drug has not been collected from the pharmacy, the patient will be offered home delivery of the drug. Additional proactive services include scheduling appointments in case patients stop taking medications, providing additional information when side effects are reported and more. All interactions generated by the system are preformed online and immediately.
Octopus Health provides a comprehensive platform that includes an AI-powered patient support solution for patients and healthcare providers. It offers patients a digital tool to manage their appointments, medications, communities, documents, educational materials and a communication channel to healthcare providers. Healthcare providers are able to initiate proactive processes through the system to manage treatment discrepancies, adherence issues, follow-ups, adverse events, recalls and more.
Dr. Doron Netzer, head of Clalit’s community medicine division, said “This service was created in view of the fact that in modern medicine we cannot maintain the concept of reactive medicine. Rather, we need to shift to a proactive approach, which helps patients make healthy decisions on an ongoing basis, not just during the patient-initiated medical encounter. Nowadays, it is crucial not only to formulate the optimal treatments for each patient, but also to ensure that the patient understands and follows the guidelines. The platform we have developed has already identified thousands of treatments where there are gaps due to a poor understanding of treatment recommendations, how to administer drugs or the occurrence of side effects, and provides patients with an adequate response. .
Clalit Chief Innovation Officer Professor Ran Balicer said “Clalit is one of the first healthcare organizations in the world to have implemented such an advanced, AI-based system to promote proactive personalized medicine. Technology finally enables us to deliver solutions that connect patients and their care providers in a way that empowers patients. and enables shared and informed decision-making. We are proud that the data assets of the business development unit of Clalit and Clalit Innovation, as well as of Octopus.Health have been able to provide unique value, which I believe will be useful to many organizations across health in the world who share similar challenges ”.
Yoav Ariav, CEO of Octopus.Health, said “The reasons why patients have difficulty adhering to treatment vary and are not simply the result of forgetting. They depend on the patient’s health knowledge, the support of his family and his close environment, cultural aspects, the patient’s self-image, his willingness to recognize the state of health at hand, the relationship of patients with their medical team, existing or perceived side effects, as well as financial aspects The objective of our platform is to emphasize to patients that their treatment serves them in achieving their goals and to associate them with its success The process led by Clalit and Octopus.Health empowers patients in their role of managing their medical conditions and creates another role in the patient journey: an AI-based personal medical assistant, serving as a link between patients and their care teams. . “
Alon schwartz, Head of IT, Digital and Data at Clalit, said “This new service is part of a global organizational approach aimed at advancing digital services adapted to patients. We have developed an AI-based system that identifies patients who need help complying with their treatment, studies their habits and communicates with them in a personalized way. manner.”
View original content: https://www.prnewswire.com/news-releases/clalit-hmo-octopushealth-and-iqvia-introduce-an-ai-based-platform-to-improve-patient-adherence-to-treatment – 301391930.html
SOURCE Octopus Health